http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113466471-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-06 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8984 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8984 |
| filingDate | 2021-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113466471-B |
| titleOfInvention | Gastric mucosa injury related biomarker, screening method and application |
| abstract | The invention discloses a gastric mucosa injury related biomarker, a screening method and application, wherein the biomarker comprises one or more of gamma-L-glutamyl-putrescine, cytosine, thymine, Ckm, Arg1, Ctps2, Pycr3 and Cmpk 2. By detecting the expression levels of gamma-L-glutamyl-putrescine, cytosine, thymine, Ckm, Arg1, Ctps2, Pycr3 and Cmpk2 in the stomach tissue of a patient with gastric diseases, the degree of damage to the gastric mucosa and the repair condition of the patient with gastric diseases can be judged. The invention discloses a method for screening a gastric mucosa injury biomarker, discloses application of the biomarker, provides theoretical support for diagnosis and treatment of patients with gastric mucosa injury, realizes early discovery and early treatment of gastric disease crowds, and has great economic value and social benefit. |
| priorityDate | 2021-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.